Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002318036 | SCV000849648 | likely benign | Inborn genetic diseases | 2017-05-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001088985 | SCV001013779 | benign | KBG syndrome | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000872029 | SCV001143028 | benign | not provided | 2018-12-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000872029 | SCV001943899 | benign | not provided | 2020-04-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001088985 | SCV002525159 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003908002 | SCV004718710 | benign | ANKRD11-related condition | 2024-02-21 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |